《大行報告》花旗:華晨(01114.HK)宣派特別息每股0.96元 較市場預期1.5元少
花旗發表研究報告指,華晨中國(01114.HK)表示經考慮財務、現金流狀況及新策略投資選項後,決議宣派特別息每股0.96元,董事會並將在於3月底前考慮是否就剩餘股權銷售餘額再發放特別息。
該行指,今次宣派的特別股息較市場普遍預期的每股1.5元少,預期市場將在未來一至兩天內作出負面反應,又指若第二次特別息亦是每股派0.96元,則合計派發每股1.92元,仍低於預期的每股3元。
花旗又指,即使華晨決議派發第二次特別股息,派發日期也可能在7月左右,距離現在還有六個月時間,兌現等待時間延長,料將加劇市場對華晨母公司與上市公司關聯交易風險的擔憂,維持「買入/高風險」評級,目標價7.1元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.